+212 661 942 375 Clinique Riad Marshan, 18 Rue Hasnouna, Ibn Hazm Avenue, Tangier
Book
Appointment
HomeAdviceHeart conditions
Heart conditionsJuly 2026Updated September 2026

Severe aortic stenosis: symptoms, life expectancy and when to operate

Narrowing of the aortic valve progresses silently for years, then everything changes once the first symptoms appear. Understanding that turning point is understanding why the timing of the operation counts as much as the operation itself.

Written by Dr Mohamed el Amine Tber, cardiovascular surgeon in Tangier

Ultrasound probe resting on the console of an ultrasound machine

The aortic narrowing, or aortic stenosis, is the commonest valve disease after sixty-five. What makes it disconcerting is that it progresses for years without showing anything, then the outlook shifts sharply the day the first symptoms arrive. Which is why the question is not only Do we have to operate?, but when.

Key figures

3 %
About 3% of people over 75 have severe aortic stenosis, and 12% have aortic stenosis of any severity. Journal of the American College of Cardiology, 2013
1 in 2
In patients too frail for surgery, half died within a year without valve replacement. PARTNER trial, New England Journal of Medicine, 2010
70 years
This is the age from which the 2025 European guidelines favour TAVI when the anatomy is suitable; below that age, surgery remains recommended for low-risk patients. ESC and EACTS, 2025
15 to 20 years
This is the usual lifespan of a biological valve; a mechanical valve lasts longer but requires anticoagulant treatment for life. NHS

The aortic valve in two sentences

The aortic valve is the heart's outlet door. With every beat it opens to let blood through into the aorta, then closes to stop it coming back. When it thickens and calcifies, that door no longer opens fully, and the heart has to push harder and harder to move the same amount of blood.

Why the valve shrinks

  • Wear and calcification, by far the commonest cause, tied to age and to cardiovascular risk factors.
  • Bicuspidia, a feature present from birth that affects about one person in a hundred: the valve has only two leaflets instead of three. It often shows up earlier, around the age of fifty or sixty, and is sometimes associated with widening of the aorta.
  • The sequelae of acute joint rheumatism, a late consequence of streptococcal throat infections poorly treated in childhood. This cause is still with us in Morocco when it has all but vanished in Europe, and it affects younger patients.

The three symptoms that change everything

Three manifestations mark the turning point of the disease:

  • Bleeding to effort, then to increasingly modest efforts;
  • Pain in the chest to the effort, to the type of tightening;
  • Unease or loss of consciousness, often at the effort.

The trap is that these signs are readily put down to age or being out of shape. Yet their arrival marks the shift from a disease you watch to a disease you have to treat. That is the most important message of this article: aortic narrowing that has become symptomatic should be taken care of without delay.

Severe aortic stenosis: how it is measured

The echocardiogram is the central test. It measures how fast blood moves through the valve, the pressure difference either side of it, and how much opening is left. Those numbers grade the severity.

SeverityOpening surfaceRoutine conduct
LightExceeding 1,5 cm2Spaced monitoring
Moderatebetween 1.0 and 1.5 cm2Annual monitoring
Locked1.0 cm² or lessSpecialized opinion, discussion of an intervention

According to the European guidelines, aortic stenosis is called severe when the valve opening area is 1 cm² or less, with a mean pressure difference of at least 40 mmHg or blood flowing through at 4 metres per second or more. When these measurements do not agree, for example when the heart is pumping weakly, other tests settle the question.

A CT scan, a supervised exercise test or a coronary angiogram sometimes round out the work-up before the decision.

Life expectancy with aortic stenosis

As long as the narrowing remains mild or moderate and causes no symptoms, the immediate risk is low and the disease is monitored. Everything changes when it becomes severe and causes symptoms. In the PARTNER trial, in patients judged too frail for surgery, half died within a year with medical treatment alone, versus less than a third after valve implantation by TAVI.

Replacing the valve at the right time therefore changes the outlook. That is what monitoring is all about: acting before the heart is damaged, without operating too early.

When do we operate?

Two situations lead to a valve replacement:

  • narrowing tight and symptomatic, whatever the age ;
  • narrowing tight without symptom, but with objective signs that the heart is struggling: a fall in contraction strength, measurements worsening quickly, or symptoms brought out by an exercise test.

Conversely, a moderate, well-tolerated narrowing is not operated on. It is monitored, and that monitoring has value: it is what allows the operation to happen at the right moment rather than too late.

Replace valve: options

Surgical replacement

The diseased valve is removed and replaced with a prosthetic one. The operation is done through a conventional sternotomy or, in some cases, through a Minimally invasive route which reduces the size of the scar and the recovery time.

TAVI

The valve is deployed inside the old one, through the arteries, without opening the chest. This technique was first reserved for frail patients, then extended to others. The 2025 European guidelines favour it from the age of 70 when the valve has three leaflets and the anatomy is suitable, whereas surgical replacement remains recommended before 70 in low-risk patients. Age is always discussed as a team, together with anatomy, life expectancy and your preferences.

Read also: minimally invasive heart surgery, answers to your questions

Biological heart valve prosthesis resting on a sterile drape
Illustrative image

Mechanical or biological

Mechanical prosthesisBiological prosthesis
LifeVery long, in principle definitiveLimited, generally 15 to 20 years
AnticoagulantLifelong, with regular blood checksMostly not in the long run
Normal profileYounger patient, biological monitoring accessibleElderly patient, or wishing to avoid anticoagulant

This is a choice to be discussed, not imposed. Your way of life, whether you can have regular blood tests, and any plan for a pregnancy weigh as heavily as your age.

Follow-up file and stethoscope in an echocardiography room
Illustrative image

After the intervention

After surgical replacement, recovery follows a pattern close to the one described in our guide to recovery after a bypass : about one week in hospital, getting up early, gradual rehabilitation and a return to activities within two to three months. After TAVI, the hospital stay is often two to three days.

Follow-up includes a baseline echocardiogram, then regular check-ups for life. Atrial fibrillation may appear afterwards or accompany the valve disease: it can be detected and treated.

Read also: normal or irregular heart rhythm, when to see a doctor

Did an ultrasound show a narrowing of your aortic valve? Dr Tber's practice in Tangier goes through your measurements, tells you exactly where you stand and whether the moment to operate has come. Book an appointment.

Frequently asked questions

What is severe aortic stenosis?
It is a severe narrowing of the aortic valve. On ultrasound, the opening area is 1 cm² or less, the mean pressure difference reaches at least 40 mmHg or blood crosses the valve at 4 metres per second or more. At this stage an intervention is discussed, especially if there are symptoms.
What is life expectancy with severe aortic stenosis?
Without symptoms, the disease is monitored closely. Once symptoms appear, the outlook becomes serious without valve replacement: in the PARTNER trial, in patients too frail for surgery, half died within a year with medical treatment alone. Replacing the valve at the right time changes this outlook.
Can we treat aortic narrowing with medication?
No. No medicine reopens a calcified valve. Medical treatment eases some symptoms and controls the risk factors, but only replacing the valve corrects the disease.
Should I operate if I have no symptoms?
A tight but totally asymptomatic narrowing is monitored, with close ultrasounds. An intervention is proposed earlier when the heart shows signs of suffering, or when the stress test reveals symptoms that the patient attributed to age.
Mechanical or biological prosthesis, which one to choose?
A mechanical valve should in principle last a lifetime but requires anticoagulant treatment for life, with regular checks. A biological valve avoids long-term anticoagulant treatment but wears out over time, generally within 15 to 20 years. Age, plans for a pregnancy, access to blood test monitoring and your way of life guide the choice.
Does TAVI replace surgery?
It has transformed it without replacing it. TAVI places a valve through the arteries without opening the chest. The 2025 European guidelines favour it from the age of 70 when the anatomy is suitable. Before 70, in a low-risk patient, surgical replacement remains recommended, because its durability is better known.

Sources and references

External resources, opened in a new tab.

  1. 2025 guidelines on valvular heart disease: what changes EACTS
  2. 2021 guidelines on valvular heart disease European Society of Cardiology and EACTS
  3. PARTNER trial: TAVI in patients who cannot have surgery New England Journal of Medicine
  4. How common aortic stenosis is after 75 Journal of the American College of Cardiology
  5. Heart valve replacement: what happens NHS
  6. Aortic valve stenosis American Heart Association

What you just read
does it concern you?

An appointment allows you to check on your case, not on a general case.